AstraZeneca PLC ADR outperforms market on strong trading day

AstraZeneca PLC ADR outperforms market on strong trading day

The AstraZeneca PLC ADR AZN, +1.43% rallied 1.43% to $57.48 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP, -0.96% falling 0.96% to 14,935.90 and Dow Jones Industrial Average DJIA, -0.01% falling 0.01% to 36,231.66. The ADR’s rise snapped a three-day losing streak. AstraZeneca PLC ADR closed $6.73 below its 52-week high ($64.21), which the company reached on November 2nd.

The ADR outperformed some of its competitors Friday, as AbbVie Inc. ABBV, -0.26% fell 0.26% to $134.88, Amgen Inc. AMGN, +0.94% rose 0.94% to $227.29, and Gilead Sciences Inc. GILD, -0.46% fell 0.46% to $71.26. Trading volume (4.6 M) remained 117,670 below its 50-day average volume of 4.7 M.

Share:
error: Content is protected !!